Less than half a month after landing on a share, kefu medical (301087) announced two acquisitions in the field of rehabilitation aids, including the well-known posture brand "Back and Back Jia", which has been popular for many years.
On the evening of November 7, Kefu Medical issued an announcement that the company intends to acquire 54.0539% of the equity of Jirui Medical Device (Shanghai) Co., Ltd. (hereinafter referred to as "Jirui Medical") at a transaction price of about 50.27 million yuan, and intends to acquire all the businesses such as the "Back-back" brand and intellectual property rights through the acquisition of 100% of the equity of Acorn Trading (Shanghai) Co., Ltd. (hereinafter referred to as "Acorn Trading") at a transaction price of 177 million yuan.
Improve the structure of rehabilitation products
The announcement shows that the "babaka" brand has a history of more than 20 years, and the main user group is teenagers. "Back and back" products have ranked first in the posture category of Tmall Mall for many consecutive years, and the health category of Jingdong Mall has been selling hot all year round, and it is the largest brand in the field of rehabilitation posture segment in China, with great market potential.
According to the summary data of Tmall and Jingdong's backend, its sales (including tax) in the last three years were 176 million yuan, 266 million yuan and 215 million yuan respectively, and the sales (including tax) from January to October 2021 were about 141 million yuan.
The company believes that the existing product categories of Kefu Medical include a number of medical rehabilitation products such as neck and waist rehabilitation, leg orthopedics, physiotherapy massage, etc., and the acquisition of "Back and Back Jia" back posture products will further improve the structure of rehabilitation products.
The company plans to take "Back and Back" as a sub-brand of rehabilitation assistive devices, unite with medical institutions such as university medical schools and large-scale top three hospitals, conduct professional clinical academic research and product upgrading and development of physical posture and shaping products, and combine the company's deep research and development accumulation in the field of multi-parameter health monitoring to create a series of orthopedic, plastic, physiotherapy and wearable medical monitoring products based on medical technology.
In addition, all of the "Back and Back" products are currently sold online through Tmall, JD.com and other platforms, which is highly overlapping with the company's existing sales channels. The announcement said that based on the company's rich experience and comprehensive operation capabilities in the field of Internet sales, as well as the extensive layout of offline pharmacies, supermarkets and other channels, the "Back and Back" series of rehabilitation products is expected to become an important revenue and profit growth point for the company.
Integrate the whole industry chain of rehabilitation aids
On the other hand, Jirui Medical is a high-tech enterprise and specialized new enterprise that develops, produces and sells intelligent rehabilitation aids such as electric wheelchairs, manual wheelchairs, and old scooters. At present, Jirui Medical has 6 invention patents, 51 utility model patents, 30 appearance patents, 70 models of electric wheelchairs and 20 models of manual wheelchairs that have obtained medical device registration certificates, and has a complete intellectual property system and leading technology research and development capabilities.
According to the data, Jirui medical products are exported to more than 30 provinces and cities in China and more than 40 countries and regions abroad, and achieve operating income of 103 million yuan in 2020. In 2021, the Nantong production base of Jirui Medical was put into use, and the annual design capacity has been increased to 250,000 units.
At the same time, among the Kefu medical rehabilitation assistive devices, wheelchair products are the largest single product, mainly purchased from their own brands, and Jirui Medical is one of the main suppliers of the company's rehabilitation products. Through the acquisition of Geri Medical, Kefu Medical will fill the gap in its independent research and development and production capacity of wheelchairs, mobility aids and other products.
At present, Kefu Medical's products cover five major areas: health monitoring, rehabilitation aids, respiratory support, medical care, and traditional Chinese medicine physiotherapy. According to the company's prospectus, from 2018 to 2020, the company's operating income of rehabilitation assistive devices products was 248 million yuan, 321 million yuan and 293 million yuan, accounting for 22.88%, 22.06% and 12.63% of the company's overall operating income. In recent years, with the growth of revenue in other categories, the proportion of the company's rehabilitation assistive devices revenue is gradually declining.
However, after the completion of the above two acquisitions, preliminary statistics show that the annual sales revenue of Kefu Medical in the field of rehabilitation aids can reach more than 600 million yuan. At the same time, the company can take this opportunity to integrate the whole industrial chain of rehabilitation assistive devices, give play to the synergy effect of both sides, cultivate new profit growth points, and further consolidate the leading position of Kefu Medical's domestic rehabilitation assistive devices industry.
![Why are the acorns that have been kicked out of the "mainstream dried fruit" called "grain trees"? You also deserve to be called Acorn? Why is acorn also called a grain tree? Why was Acorn kicked out?[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)